[ET Net News Agency, 28 May 2024] UBS raised the target price for CSPC Pharma (01093) to
HKD10.1 from HKD9.3 and maintained the "buy" rating.
The research house said it revises up revenue growth assumption for 2024 (9.8% vs prior
6.8%). (rc)
28/05/2024 15:10
{I-bank focus}UBS raises CSPC Pharma (01093) to HKD10.1
[ET Net News Agency, 28 May 2024] UBS raised the target price for CSPC Pharma (01093) to
HKD10.1 from HKD9.3 and maintained the "buy" rating.
The research house said it revises up revenue growth assumption for 2024 (9.8% vs prior
6.8%). (rc)
Previous︰28/05/2024 15:51 {I-bank focus}Daiwa raises CSPC Pharma (01093) to HKD8
Next︰26/02/2024 15:55 {I-bank focus}HSBC lowers CSPC Pharma (01093) to HKD7.25
31/05/2024 15:01 {I-bank focus}Goldman raises CSPC Pharma (01093) to HKD10.26
20/02/2024 14:31 {I-bank focus}BofA lowers CSPC Pharma (01093) to HKD5.9
Remark: | Real time quote last updated: 02/07/2024 08:58 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |